SNPX logo

Synaptogenix (SNPX) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

08 December 2020

Indexes:

Not included

Description:

Synaptogenix, Inc. (SNPX) is a biotechnology company focused on developing treatments for neurological disorders. They aim to improve brain health and cognitive function through innovative therapies, particularly for conditions like Alzheimer's disease. Their research emphasizes enhancing synaptic connections in the brain to support better mental performance.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 05, 2024

Analyst ratings

Recent major analysts updates

11 July '24 Maxim Group
Buy
19 Dec '22 Maxim Group
Hold
12 Apr '22 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

FAQ

  • What is the primary business of Synaptogenix?
  • What is the ticker symbol for Synaptogenix?
  • Does Synaptogenix pay dividends?
  • What sector is Synaptogenix in?
  • What industry is Synaptogenix in?
  • What country is Synaptogenix based in?
  • When did Synaptogenix go public?
  • Is Synaptogenix in the S&P 500?
  • Is Synaptogenix in the NASDAQ 100?
  • Is Synaptogenix in the Dow Jones?
  • When was Synaptogenix's last earnings report?
  • When does Synaptogenix report earnings?
  • Should I buy Synaptogenix stock now?

What is the primary business of Synaptogenix?

Synaptogenix, Inc. (SNPX) is a biotechnology company focused on developing treatments for neurological disorders. They aim to improve brain health and cognitive function through innovative therapies, particularly for conditions like Alzheimer's disease. Their research emphasizes enhancing synaptic connections in the brain to support better mental performance.

What is the ticker symbol for Synaptogenix?

The ticker symbol for Synaptogenix is NASDAQ:SNPX

Does Synaptogenix pay dividends?

No, Synaptogenix does not pay dividends

What sector is Synaptogenix in?

Synaptogenix is in the Healthcare sector

What industry is Synaptogenix in?

Synaptogenix is in the Biotechnology industry

What country is Synaptogenix based in?

Synaptogenix is headquartered in United States

When did Synaptogenix go public?

Synaptogenix's initial public offering (IPO) was on 08 December 2020

Is Synaptogenix in the S&P 500?

No, Synaptogenix is not included in the S&P 500 index

Is Synaptogenix in the NASDAQ 100?

No, Synaptogenix is not included in the NASDAQ 100 index

Is Synaptogenix in the Dow Jones?

No, Synaptogenix is not included in the Dow Jones index

When was Synaptogenix's last earnings report?

Synaptogenix's most recent earnings report was on 12 November 2024

When does Synaptogenix report earnings?

The next expected earnings date for Synaptogenix is 15 May 2025

Should I buy Synaptogenix stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions